Hoppa till innehåll
Pelago Bioscience Logotype for Pelago bioscience
  • Services
    • CETSA®
      • Unbiased Profiling
        • Proteome wide
        • Selectivity Profiling
      • Targeted Profiling
  • Drug Discovery Phases
    • Target Discovery
      • Target Identification and Deconvolution
    • Lead Generation
      • Primary Screening
      • Hit Confirmation
      • Potency Ranking 
      • Selectivity Profiling
    • Lead Optimization
      • Potency Ranking 
      • Selectivity Profiling
      • Target Identification and Deconvolution
      • Mechanism of Action
      • Translational Studies
    • Preclinical Studies
      • Translational Studies
      • In Vivo Target Engagement
      • Biomarker Discovery
  • About CETSA®
    • Why CETSA?
    • Your key to biological relevance
  • Case Stories
  • About us
    • Our story
    • Our facilities
  • News & Events
  • Blog
  • Contact Us
    • Contact us
    • Career
    • Whistleblowing
  • Scientific Hub

Pär Nordlund, Professor and Inventor of CETSA

March 12, 2025

Martin Bonde, CEO

January 21, 2025

Ola Sandborgh, CEO

June 25, 2024

Thomas Lundbäck, Senior Director

June 25, 2024

Po-Shun Lee, Chief Medical Officer

See more
Logotype for Pelago bioscience

Pelago Bioscience AB
Scheeles väg 1
171 65 Solna
Sweden

  • About us
    • Our facilities
  • Drug Discovery Phases
    • Target Discovery
    • Lead Optimization
    • Lead Generation
    • Preclinical Studies
  • About CETSA®
    • Your key to biological relevance
  • News & Events
    • Contact Us
    • Whistleblowing
    • Login
Login
Subscribe to our newsletter

© 2026 Pelago Bioscience

Privacy policy
Let's discuss your project